- Home
- JEQ vs VSTM Comparison
JEQ vs VSTM Comparison
Compare JEQ & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEQ
- VSTM
- Stock Information
- Founded
- JEQ 1990
- VSTM 2010
- Country
- JEQ United States
- VSTM United States
- Employees
- JEQ N/A
- VSTM N/A
- Industry
- JEQ Air Freight/Delivery Services
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- JEQ Consumer Discretionary
- VSTM Health Care
- Exchange
- JEQ Nasdaq
- VSTM Nasdaq
- Market Cap
- JEQ 99.8M
- VSTM 425.9M
- IPO Year
- JEQ N/A
- VSTM 2012
- Fundamental
- Price
- JEQ $7.29
- VSTM $4.69
- Analyst Decision
- JEQ
- VSTM Strong Buy
- Analyst Count
- JEQ 0
- VSTM 9
- Target Price
- JEQ N/A
- VSTM $12.63
- AVG Volume (30 Days)
- JEQ 32.0K
- VSTM 2.5M
- Earning Date
- JEQ 01-01-0001
- VSTM 08-07-2025
- Dividend Yield
- JEQ 7.05%
- VSTM N/A
- EPS Growth
- JEQ N/A
- VSTM N/A
- EPS
- JEQ N/A
- VSTM N/A
- Revenue
- JEQ N/A
- VSTM $10,000,000.00
- Revenue This Year
- JEQ N/A
- VSTM $129.06
- Revenue Next Year
- JEQ N/A
- VSTM $306.32
- P/E Ratio
- JEQ N/A
- VSTM N/A
- Revenue Growth
- JEQ N/A
- VSTM N/A
- 52 Week Low
- JEQ $4.99
- VSTM $2.10
- 52 Week High
- JEQ $6.39
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- JEQ 51.52
- VSTM 39.03
- Support Level
- JEQ $7.24
- VSTM $4.60
- Resistance Level
- JEQ $7.62
- VSTM $4.90
- Average True Range (ATR)
- JEQ 0.09
- VSTM 0.32
- MACD
- JEQ -0.02
- VSTM 0.10
- Stochastic Oscillator
- JEQ 51.47
- VSTM 64.29
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.